AMN Healthcare Services, Inc. (AMN) Stock Competitors & Peer Comparison
See (AMN) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AMN | $31.36 | +1.03% | 1.2B | -35.27 | -$0.86 | N/A |
| HCA | $385.98 | +6.82% | 83.2B | 12.91 | $29.03 | +0.79% |
| THC | $176.93 | +8.54% | 14.3B | 8.65 | $19.24 | N/A |
| SOLV | $78.51 | -0.32% | 14.3B | 10.09 | $8.17 | N/A |
| DVA | $210.71 | +9.70% | 12.7B | 19.11 | $10.37 | N/A |
| FMS | $22.97 | +5.42% | 12B | 11.76 | $1.90 | +3.88% |
| EHC | $102.74 | +1.61% | 10.3B | 17.84 | $5.84 | +0.72% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| UHS | $146.62 | +2.62% | 9.2B | 6.12 | $23.95 | +0.55% |
| ENSG | $149.15 | -4.65% | 9.1B | 25.29 | $6.14 | +0.17% |
Stock Comparison
AMN vs HCA Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, HCA has a market cap of 83.2B. Regarding current trading prices, AMN is priced at $31.36, while HCA trades at $385.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas HCA's P/E ratio is 12.91. In terms of profitability, AMN's ROE is -0.05%, compared to HCA's ROE of -1.23%. Regarding short-term risk, AMN is more volatile compared to HCA. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check HCA's competition here
AMN vs THC Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, THC has a market cap of 14.3B. Regarding current trading prices, AMN is priced at $31.36, while THC trades at $176.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas THC's P/E ratio is 8.65. In terms of profitability, AMN's ROE is -0.05%, compared to THC's ROE of +0.41%. Regarding short-term risk, AMN is more volatile compared to THC. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check THC's competition here
AMN vs SOLV Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, SOLV has a market cap of 14.3B. Regarding current trading prices, AMN is priced at $31.36, while SOLV trades at $78.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas SOLV's P/E ratio is 10.09. In terms of profitability, AMN's ROE is -0.05%, compared to SOLV's ROE of +0.31%. Regarding short-term risk, AMN is more volatile compared to SOLV. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check SOLV's competition here
AMN vs DVA Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, DVA has a market cap of 12.7B. Regarding current trading prices, AMN is priced at $31.36, while DVA trades at $210.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas DVA's P/E ratio is 19.11. In terms of profitability, AMN's ROE is -0.05%, compared to DVA's ROE of -1.33%. Regarding short-term risk, AMN is less volatile compared to DVA. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check DVA's competition here
AMN vs FMS Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, FMS has a market cap of 12B. Regarding current trading prices, AMN is priced at $31.36, while FMS trades at $22.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas FMS's P/E ratio is 11.76. In terms of profitability, AMN's ROE is -0.05%, compared to FMS's ROE of +0.07%. Regarding short-term risk, AMN is more volatile compared to FMS. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check FMS's competition here
AMN vs EHC Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, EHC has a market cap of 10.3B. Regarding current trading prices, AMN is priced at $31.36, while EHC trades at $102.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas EHC's P/E ratio is 17.84. In terms of profitability, AMN's ROE is -0.05%, compared to EHC's ROE of +0.25%. Regarding short-term risk, AMN is less volatile compared to EHC. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check EHC's competition here
AMN vs OSH Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, AMN is priced at $31.36, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas OSH's P/E ratio is -17.65. In terms of profitability, AMN's ROE is -0.05%, compared to OSH's ROE of +4.64%. Regarding short-term risk, AMN is more volatile compared to OSH. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check OSH's competition here
AMN vs UHS Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, UHS has a market cap of 9.2B. Regarding current trading prices, AMN is priced at $31.36, while UHS trades at $146.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas UHS's P/E ratio is 6.12. In terms of profitability, AMN's ROE is -0.05%, compared to UHS's ROE of +0.21%. Regarding short-term risk, AMN is more volatile compared to UHS. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check UHS's competition here
AMN vs ENSG Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, ENSG has a market cap of 9.1B. Regarding current trading prices, AMN is priced at $31.36, while ENSG trades at $149.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas ENSG's P/E ratio is 25.29. In terms of profitability, AMN's ROE is -0.05%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, AMN is less volatile compared to ENSG. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check ENSG's competition here
AMN vs CHE Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, CHE has a market cap of 5.9B. Regarding current trading prices, AMN is priced at $31.36, while CHE trades at $418.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas CHE's P/E ratio is 24.35. In terms of profitability, AMN's ROE is -0.05%, compared to CHE's ROE of +0.25%. Regarding short-term risk, AMN is more volatile compared to CHE. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check CHE's competition here
AMN vs LHCG Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, AMN is priced at $31.36, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas LHCG's P/E ratio is 82.83. In terms of profitability, AMN's ROE is -0.05%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, AMN is more volatile compared to LHCG. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check LHCG's competition here
AMN vs MMED Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, MMED has a market cap of 4.2B. Regarding current trading prices, AMN is priced at $31.36, while MMED trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas MMED's P/E ratio is -11.91. In terms of profitability, AMN's ROE is -0.05%, compared to MMED's ROE of -0.09%. Regarding short-term risk, AMN is less volatile compared to MMED. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check MMED's competition here
AMN vs AMED Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, AMN is priced at $31.36, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas AMED's P/E ratio is 39.30. In terms of profitability, AMN's ROE is -0.05%, compared to AMED's ROE of +0.09%. Regarding short-term risk, AMN is more volatile compared to AMED. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check AMED's competition here
AMN vs OPCH Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, OPCH has a market cap of 3.3B. Regarding current trading prices, AMN is priced at $31.36, while OPCH trades at $20.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas OPCH's P/E ratio is 16.49. In terms of profitability, AMN's ROE is -0.05%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, AMN is more volatile compared to OPCH. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check OPCH's competition here
AMN vs BKD Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, BKD has a market cap of 3.1B. Regarding current trading prices, AMN is priced at $31.36, while BKD trades at $13.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas BKD's P/E ratio is -14.78. In terms of profitability, AMN's ROE is -0.05%, compared to BKD's ROE of +401.19%. Regarding short-term risk, AMN is less volatile compared to BKD. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check BKD's competition here
AMN vs NHC Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, NHC has a market cap of 3B. Regarding current trading prices, AMN is priced at $31.36, while NHC trades at $198.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas NHC's P/E ratio is 24.38. In terms of profitability, AMN's ROE is -0.05%, compared to NHC's ROE of +0.12%. Regarding short-term risk, AMN is less volatile compared to NHC. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check NHC's competition here
AMN vs LFST Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, LFST has a market cap of 3B. Regarding current trading prices, AMN is priced at $31.36, while LFST trades at $8.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas LFST's P/E ratio is 127.67. In terms of profitability, AMN's ROE is -0.05%, compared to LFST's ROE of +0.02%. Regarding short-term risk, AMN is more volatile compared to LFST. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check LFST's competition here
AMN vs ACHC Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, ACHC has a market cap of 2.3B. Regarding current trading prices, AMN is priced at $31.36, while ACHC trades at $25.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas ACHC's P/E ratio is -2.09. In terms of profitability, AMN's ROE is -0.05%, compared to ACHC's ROE of -0.44%. Regarding short-term risk, AMN is more volatile compared to ACHC. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check ACHC's competition here
AMN vs SEM Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, SEM has a market cap of 2.1B. Regarding current trading prices, AMN is priced at $31.36, while SEM trades at $16.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas SEM's P/E ratio is 15.54. In terms of profitability, AMN's ROE is -0.05%, compared to SEM's ROE of +0.08%. Regarding short-term risk, AMN is more volatile compared to SEM. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check SEM's competition here
AMN vs MD Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, MD has a market cap of 1.9B. Regarding current trading prices, AMN is priced at $31.36, while MD trades at $24.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas MD's P/E ratio is 11.49. In terms of profitability, AMN's ROE is -0.05%, compared to MD's ROE of +0.20%. Regarding short-term risk, AMN is more volatile compared to MD. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check MD's competition here
AMN vs ASTH Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, ASTH has a market cap of 1.9B. Regarding current trading prices, AMN is priced at $31.36, while ASTH trades at $39.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas ASTH's P/E ratio is 62.77. In terms of profitability, AMN's ROE is -0.05%, compared to ASTH's ROE of +0.04%. Regarding short-term risk, AMN is more volatile compared to ASTH. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check ASTH's competition here
AMN vs AMEH Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, AMN is priced at $31.36, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas AMEH's P/E ratio is 39.25. In terms of profitability, AMN's ROE is -0.05%, compared to AMEH's ROE of +0.04%. Regarding short-term risk, AMN is less volatile compared to AMEH. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check AMEH's competition here
AMN vs SGRY Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, SGRY has a market cap of 1.8B. Regarding current trading prices, AMN is priced at $31.36, while SGRY trades at $15.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas SGRY's P/E ratio is -23.66. In terms of profitability, AMN's ROE is -0.05%, compared to SGRY's ROE of -0.04%. Regarding short-term risk, AMN is less volatile compared to SGRY. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check SGRY's competition here
AMN vs ADUS Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, ADUS has a market cap of 1.7B. Regarding current trading prices, AMN is priced at $31.36, while ADUS trades at $94.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas ADUS's P/E ratio is 17.10. In terms of profitability, AMN's ROE is -0.05%, compared to ADUS's ROE of +0.09%. Regarding short-term risk, AMN is more volatile compared to ADUS. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check ADUS's competition here
AMN vs AGL Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, AGL has a market cap of 1.7B. Regarding current trading prices, AMN is priced at $31.36, while AGL trades at $111.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas AGL's P/E ratio is -4.52. In terms of profitability, AMN's ROE is -0.05%, compared to AGL's ROE of -1.46%. Regarding short-term risk, AMN is less volatile compared to AGL. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check AGL's competition here
AMN vs AVAH Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, AVAH has a market cap of 1.5B. Regarding current trading prices, AMN is priced at $31.36, while AVAH trades at $7.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas AVAH's P/E ratio is 5.68. In terms of profitability, AMN's ROE is -0.05%, compared to AVAH's ROE of +2.41%. Regarding short-term risk, AMN is less volatile compared to AVAH. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check AVAH's competition here
AMN vs HCSG Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, AMN is priced at $31.36, while HCSG trades at $22.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas HCSG's P/E ratio is 22.43. In terms of profitability, AMN's ROE is -0.05%, compared to HCSG's ROE of +0.14%. Regarding short-term risk, AMN is more volatile compared to HCSG. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check HCSG's competition here
AMN vs ARDT Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, ARDT has a market cap of 1.3B. Regarding current trading prices, AMN is priced at $31.36, while ARDT trades at $9.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas ARDT's P/E ratio is 9.91. In terms of profitability, AMN's ROE is -0.05%, compared to ARDT's ROE of +0.09%. Regarding short-term risk, AMN is less volatile compared to ARDT. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check ARDT's competition here
AMN vs BKDT Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, AMN is priced at $31.36, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas BKDT's P/E ratio is N/A. In terms of profitability, AMN's ROE is -0.05%, compared to BKDT's ROE of +401.19%. Regarding short-term risk, AMN is more volatile compared to BKDT. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check BKDT's competition here
AMN vs PNTG Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, PNTG has a market cap of 1.1B. Regarding current trading prices, AMN is priced at $31.36, while PNTG trades at $32.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas PNTG's P/E ratio is 38.10. In terms of profitability, AMN's ROE is -0.05%, compared to PNTG's ROE of +0.09%. Regarding short-term risk, AMN is more volatile compared to PNTG. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check PNTG's competition here
AMN vs CMPS Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, CMPS has a market cap of 1.1B. Regarding current trading prices, AMN is priced at $31.36, while CMPS trades at $12.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas CMPS's P/E ratio is -3.59. In terms of profitability, AMN's ROE is -0.05%, compared to CMPS's ROE of -1.51%. Regarding short-term risk, AMN is less volatile compared to CMPS. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check CMPS's competition here
AMN vs INNV Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, INNV has a market cap of 1B. Regarding current trading prices, AMN is priced at $31.36, while INNV trades at $9.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas INNV's P/E ratio is -96.12. In terms of profitability, AMN's ROE is -0.05%, compared to INNV's ROE of -0.09%. Regarding short-term risk, AMN is less volatile compared to INNV. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check INNV's competition here
AMN vs USPH Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, USPH has a market cap of 940.5M. Regarding current trading prices, AMN is priced at $31.36, while USPH trades at $66.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas USPH's P/E ratio is 123.60. In terms of profitability, AMN's ROE is -0.05%, compared to USPH's ROE of +0.00%. Regarding short-term risk, AMN is more volatile compared to USPH. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check USPH's competition here
AMN vs TALK Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, TALK has a market cap of 872.7M. Regarding current trading prices, AMN is priced at $31.36, while TALK trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas TALK's P/E ratio is 130.25. In terms of profitability, AMN's ROE is -0.05%, compared to TALK's ROE of +0.01%. Regarding short-term risk, AMN is more volatile compared to TALK. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check TALK's competition here
AMN vs FSHCX Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, FSHCX has a market cap of 806.7M. Regarding current trading prices, AMN is priced at $31.36, while FSHCX trades at $113.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas FSHCX's P/E ratio is N/A. In terms of profitability, AMN's ROE is -0.05%, compared to FSHCX's ROE of N/A. Regarding short-term risk, AMN is more volatile compared to FSHCX. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check FSHCX's competition here
AMN vs SNDA Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, SNDA has a market cap of 713.2M. Regarding current trading prices, AMN is priced at $31.36, while SNDA trades at $35.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas SNDA's P/E ratio is -6.27. In terms of profitability, AMN's ROE is -0.05%, compared to SNDA's ROE of -0.35%. Regarding short-term risk, AMN is more volatile compared to SNDA. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check SNDA's competition here
AMN vs EHAB Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, AMN is priced at $31.36, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas EHAB's P/E ratio is -197.14. In terms of profitability, AMN's ROE is -0.05%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, AMN is more volatile compared to EHAB. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check EHAB's competition here
AMN vs GMRS Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, GMRS has a market cap of 529.7M. Regarding current trading prices, AMN is priced at $31.36, while GMRS trades at $13.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas GMRS's P/E ratio is 6.02. In terms of profitability, AMN's ROE is -0.05%, compared to GMRS's ROE of N/A. Regarding short-term risk, AMN is less volatile compared to GMRS. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check GMRS's competition here
AMN vs TOI Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, TOI has a market cap of 495.9M. Regarding current trading prices, AMN is priced at $31.36, while TOI trades at $5.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas TOI's P/E ratio is -14.17. In terms of profitability, AMN's ROE is -0.05%, compared to TOI's ROE of +3.27%. Regarding short-term risk, AMN is less volatile compared to TOI. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check TOI's competition here
AMN vs MCTA Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, AMN is priced at $31.36, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas MCTA's P/E ratio is 419.36. In terms of profitability, AMN's ROE is -0.05%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, AMN is more volatile compared to MCTA. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check MCTA's competition here
AMN vs CCRN Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, CCRN has a market cap of 435M. Regarding current trading prices, AMN is priced at $31.36, while CCRN trades at $13.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas CCRN's P/E ratio is -4.32. In terms of profitability, AMN's ROE is -0.05%, compared to CCRN's ROE of -0.27%. Regarding short-term risk, AMN is more volatile compared to CCRN. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check CCRN's competition here
AMN vs CYH Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, CYH has a market cap of 404.4M. Regarding current trading prices, AMN is priced at $31.36, while CYH trades at $3.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas CYH's P/E ratio is 0.83. In terms of profitability, AMN's ROE is -0.05%, compared to CYH's ROE of +0.06%. Regarding short-term risk, AMN is more volatile compared to CYH. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check CYH's competition here
AMN vs AIRS Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, AIRS has a market cap of 372.5M. Regarding current trading prices, AMN is priced at $31.36, while AIRS trades at $5.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas AIRS's P/E ratio is -31.06. In terms of profitability, AMN's ROE is -0.05%, compared to AIRS's ROE of -0.12%. Regarding short-term risk, AMN is less volatile compared to AIRS. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check AIRS's competition here
AMN vs AUNA Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, AUNA has a market cap of 356M. Regarding current trading prices, AMN is priced at $31.36, while AUNA trades at $4.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas AUNA's P/E ratio is 17.81. In terms of profitability, AMN's ROE is -0.05%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, AMN is more volatile compared to AUNA. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check AUNA's competition here
AMN vs CSU Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, AMN is priced at $31.36, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas CSU's P/E ratio is 0.67. In terms of profitability, AMN's ROE is -0.05%, compared to CSU's ROE of -0.51%. Regarding short-term risk, AMN is less volatile compared to CSU. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check CSU's competition here
AMN vs JYNT Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, JYNT has a market cap of 119.9M. Regarding current trading prices, AMN is priced at $31.36, while JYNT trades at $9.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas JYNT's P/E ratio is 93.44. In terms of profitability, AMN's ROE is -0.05%, compared to JYNT's ROE of +0.17%. Regarding short-term risk, AMN is more volatile compared to JYNT. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check JYNT's competition here
AMN vs NAKAW Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, NAKAW has a market cap of 116.4M. Regarding current trading prices, AMN is priced at $31.36, while NAKAW trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas NAKAW's P/E ratio is N/A. In terms of profitability, AMN's ROE is -0.05%, compared to NAKAW's ROE of -0.85%. Regarding short-term risk, AMN is less volatile compared to NAKAW. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check NAKAW's competition here
AMN vs FVE Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, AMN is priced at $31.36, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas FVE's P/E ratio is -5.64. In terms of profitability, AMN's ROE is -0.05%, compared to FVE's ROE of -0.15%. Regarding short-term risk, AMN is more volatile compared to FVE. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check FVE's competition here
AMN vs BTMD Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, BTMD has a market cap of 97.5M. Regarding current trading prices, AMN is priced at $31.36, while BTMD trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas BTMD's P/E ratio is 5.14. In terms of profitability, AMN's ROE is -0.05%, compared to BTMD's ROE of -0.23%. Regarding short-term risk, AMN is less volatile compared to BTMD. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check BTMD's competition here
AMN vs KDLYW Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, AMN is priced at $31.36, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas KDLYW's P/E ratio is N/A. In terms of profitability, AMN's ROE is -0.05%, compared to KDLYW's ROE of -0.85%. Regarding short-term risk, AMN is less volatile compared to KDLYW. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check KDLYW's competition here
AMN vs DCGO Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, DCGO has a market cap of 57.2M. Regarding current trading prices, AMN is priced at $31.36, while DCGO trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas DCGO's P/E ratio is -0.30. In terms of profitability, AMN's ROE is -0.05%, compared to DCGO's ROE of -0.89%. Regarding short-term risk, AMN is more volatile compared to DCGO. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check DCGO's competition here
AMN vs ALR Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, AMN is priced at $31.36, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas ALR's P/E ratio is -1.11. In terms of profitability, AMN's ROE is -0.05%, compared to ALR's ROE of -0.15%. Regarding short-term risk, AMN is more volatile compared to ALR. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check ALR's competition here
AMN vs PIII Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, PIII has a market cap of 41.3M. Regarding current trading prices, AMN is priced at $31.36, while PIII trades at $13.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas PIII's P/E ratio is -0.32. In terms of profitability, AMN's ROE is -0.05%, compared to PIII's ROE of +1.85%. Regarding short-term risk, AMN is less volatile compared to PIII. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check PIII's competition here
AMN vs IMAC Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, AMN is priced at $31.36, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas IMAC's P/E ratio is -2.27. In terms of profitability, AMN's ROE is -0.05%, compared to IMAC's ROE of +5.81%. Regarding short-term risk, AMN is more volatile compared to IMAC. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check IMAC's competition here
AMN vs CCEL Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, CCEL has a market cap of 29.3M. Regarding current trading prices, AMN is priced at $31.36, while CCEL trades at $3.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas CCEL's P/E ratio is -11.37. In terms of profitability, AMN's ROE is -0.05%, compared to CCEL's ROE of +0.16%. Regarding short-term risk, AMN is less volatile compared to CCEL. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check CCEL's competition here
AMN vs CANO-WT Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, AMN is priced at $31.36, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, AMN's ROE is -0.05%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, AMN is less volatile compared to CANO-WT. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check CANO-WT's competition here
AMN vs AIH Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, AMN is priced at $31.36, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas AIH's P/E ratio is -2.78. In terms of profitability, AMN's ROE is -0.05%, compared to AIH's ROE of +1.16%. Regarding short-term risk, AMN is less volatile compared to AIH. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check AIH's competition here
AMN vs CANO Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, AMN is priced at $31.36, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas CANO's P/E ratio is -0.01. In terms of profitability, AMN's ROE is -0.05%, compared to CANO's ROE of -1.49%. Regarding short-term risk, AMN is less volatile compared to CANO. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check CANO's competition here
AMN vs AMS Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, AMS has a market cap of 9.9M. Regarding current trading prices, AMN is priced at $31.36, while AMS trades at $1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas AMS's P/E ratio is -6.82. In terms of profitability, AMN's ROE is -0.05%, compared to AMS's ROE of -0.06%. Regarding short-term risk, AMN is more volatile compared to AMS. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check AMS's competition here
AMN vs FTRP Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, AMN is priced at $31.36, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas FTRP's P/E ratio is -1.22. In terms of profitability, AMN's ROE is -0.05%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, AMN is less volatile compared to FTRP. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check FTRP's competition here
AMN vs MODV Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, AMN is priced at $31.36, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas MODV's P/E ratio is -0.03. In terms of profitability, AMN's ROE is -0.05%, compared to MODV's ROE of +1.84%. Regarding short-term risk, AMN is more volatile compared to MODV. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check MODV's competition here
AMN vs TOIIW Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, TOIIW has a market cap of 5.9M. Regarding current trading prices, AMN is priced at $31.36, while TOIIW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas TOIIW's P/E ratio is N/A. In terms of profitability, AMN's ROE is -0.05%, compared to TOIIW's ROE of +3.27%. Regarding short-term risk, AMN is less volatile compared to TOIIW. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check TOIIW's competition here
AMN vs GBNH Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, AMN is priced at $31.36, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas GBNH's P/E ratio is -0.06. In terms of profitability, AMN's ROE is -0.05%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, AMN is less volatile compared to GBNH. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check GBNH's competition here
AMN vs RHE Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, AMN is priced at $31.36, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas RHE's P/E ratio is -1.79. In terms of profitability, AMN's ROE is -0.05%, compared to RHE's ROE of -0.36%. Regarding short-term risk, AMN is less volatile compared to RHE. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check RHE's competition here
AMN vs RHE-PA Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, AMN is priced at $31.36, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, AMN's ROE is -0.05%, compared to RHE-PA's ROE of +2.11%. Regarding short-term risk, AMN is less volatile compared to RHE-PA. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check RHE-PA's competition here
AMN vs IMACW Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, AMN is priced at $31.36, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas IMACW's P/E ratio is N/A. In terms of profitability, AMN's ROE is -0.05%, compared to IMACW's ROE of +1.05%. Regarding short-term risk, AMN is less volatile compared to IMACW. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check IMACW's competition here
AMN vs CCM Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, CCM has a market cap of 685.8K. Regarding current trading prices, AMN is priced at $31.36, while CCM trades at $4.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas CCM's P/E ratio is -1.50. In terms of profitability, AMN's ROE is -0.05%, compared to CCM's ROE of +0.07%. Regarding short-term risk, AMN is more volatile compared to CCM. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check CCM's competition here
AMN vs TALKW Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, TALKW has a market cap of 653.3K. Regarding current trading prices, AMN is priced at $31.36, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas TALKW's P/E ratio is N/A. In terms of profitability, AMN's ROE is -0.05%, compared to TALKW's ROE of +0.01%. Regarding short-term risk, AMN is less volatile compared to TALKW. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check TALKW's competition here
AMN vs MNDR Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, MNDR has a market cap of 618.3K. Regarding current trading prices, AMN is priced at $31.36, while MNDR trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas MNDR's P/E ratio is -0.29. In terms of profitability, AMN's ROE is -0.05%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, AMN is less volatile compared to MNDR. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check MNDR's competition here
AMN vs NIVF Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, NIVF has a market cap of 279.7K. Regarding current trading prices, AMN is priced at $31.36, while NIVF trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas NIVF's P/E ratio is 0.01. In terms of profitability, AMN's ROE is -0.05%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, AMN is less volatile compared to NIVF. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check NIVF's competition here
AMN vs NIVFW Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, NIVFW has a market cap of 45.5K. Regarding current trading prices, AMN is priced at $31.36, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas NIVFW's P/E ratio is N/A. In terms of profitability, AMN's ROE is -0.05%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, AMN is less volatile compared to NIVFW. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check NIVFW's competition here
AMN vs PIIIW Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, PIIIW has a market cap of 42.2K. Regarding current trading prices, AMN is priced at $31.36, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas PIIIW's P/E ratio is -0.01. In terms of profitability, AMN's ROE is -0.05%, compared to PIIIW's ROE of +1.85%. Regarding short-term risk, AMN is less volatile compared to PIIIW. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check PIIIW's competition here
AMN vs AFAM Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, AMN is priced at $31.36, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas AFAM's P/E ratio is N/A. In terms of profitability, AMN's ROE is -0.05%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, AMN is less volatile compared to AFAM. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check AFAM's competition here
AMN vs KND Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, KND has a market cap of 0. Regarding current trading prices, AMN is priced at $31.36, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas KND's P/E ratio is N/A. In terms of profitability, AMN's ROE is -0.05%, compared to KND's ROE of -0.53%. Regarding short-term risk, AMN is more volatile compared to KND. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check KND's competition here
AMN vs SLHG Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, AMN is priced at $31.36, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas SLHG's P/E ratio is -1.48. In terms of profitability, AMN's ROE is -0.05%, compared to SLHG's ROE of N/A. Regarding short-term risk, AMN is less volatile compared to SLHG. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check SLHG's competition here
AMN vs TVTY Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, AMN is priced at $31.36, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas TVTY's P/E ratio is 19.06. In terms of profitability, AMN's ROE is -0.05%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, AMN is more volatile compared to TVTY. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check TVTY's competition here
AMN vs DVCR Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, AMN is priced at $31.36, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas DVCR's P/E ratio is 28.34. In terms of profitability, AMN's ROE is -0.05%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, AMN is more volatile compared to DVCR. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check DVCR's competition here
AMN vs SLHGP Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, AMN is priced at $31.36, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, AMN's ROE is -0.05%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, AMN is more volatile compared to SLHGP. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check SLHGP's competition here
AMN vs DCGOW Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, AMN is priced at $31.36, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas DCGOW's P/E ratio is N/A. In terms of profitability, AMN's ROE is -0.05%, compared to DCGOW's ROE of -0.89%. Regarding short-term risk, AMN is less volatile compared to DCGOW. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check DCGOW's competition here
AMN vs HNGR Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, AMN is priced at $31.36, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas HNGR's P/E ratio is 19.71. In terms of profitability, AMN's ROE is -0.05%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, AMN is more volatile compared to HNGR. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check HNGR's competition here
AMN vs TLMDW Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, AMN is priced at $31.36, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas TLMDW's P/E ratio is N/A. In terms of profitability, AMN's ROE is -0.05%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, AMN is less volatile compared to TLMDW. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check TLMDW's competition here
AMN vs ATIP-WT Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, AMN is priced at $31.36, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, AMN's ROE is -0.05%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, AMN is less volatile compared to ATIP-WT. This indicates potentially lower risk in terms of short-term price fluctuations for AMN.Check ATIP-WT's competition here
AMN vs TLMD Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, AMN is priced at $31.36, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas TLMD's P/E ratio is -1.60. In terms of profitability, AMN's ROE is -0.05%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, AMN is more volatile compared to TLMD. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check TLMD's competition here
AMN vs NFH Comparison June 2026
AMN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMN stands at 1.2B. In comparison, NFH has a market cap of 0. Regarding current trading prices, AMN is priced at $31.36, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMN currently has a P/E ratio of -35.27, whereas NFH's P/E ratio is -19.75. In terms of profitability, AMN's ROE is -0.05%, compared to NFH's ROE of -0.06%. Regarding short-term risk, AMN is more volatile compared to NFH. This indicates potentially higher risk in terms of short-term price fluctuations for AMN.Check NFH's competition here